Discovery of a novel Kv7 channel opener as a treatment for epilepsy
- 1 November 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (21) , 4941-4944
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based DrugsCurrent Medicinal Chemistry, 2014
- Kv7 channels as targets for anti-epileptic and psychiatric drug-developmentEuropean Journal of Pharmacology, 2014
- The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: A systematic review and indirect comparisonSeizure: European Journal of Epilepsy, 2012
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike PropertiesACS Chemical Neuroscience, 2010
- Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysisBioorganic & Medicinal Chemistry Letters, 2009
- Nervous system KV7 disorders: breakdown of a subthreshold brakeThe Journal of Physiology, 2008
- Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugsCurrent Opinion in Pharmacology, 2008
- KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrumBrain, 2003
- Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complexEuropean Journal of Pharmacology, 2003
- Electrophilic Tetraalkylammonium Nitrate Nitration. II. Improved Anhydrous Aromatic and Heteroaromatic Mononitration with Tetramethylammonium Nitrate and Triflic Anhydride, Including Selected Microwave ExamplesThe Journal of Organic Chemistry, 2002